BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPLICATIONS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, providing promising enhancements across various health care and industrial purposes. With its structural similarity to naturally derived human serum albumin, OsrHSA provides a safer, far more trustworthy alternate for therapeutic us